0001493152-21-004804.txt : 20210225 0001493152-21-004804.hdr.sgml : 20210225 20210225124142 ACCESSION NUMBER: 0001493152-21-004804 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20210225 FILED AS OF DATE: 20210225 DATE AS OF CHANGE: 20210225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biofrontera AG CENTRAL INDEX KEY: 0001712641 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: 2M FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38396 FILM NUMBER: 21678435 BUSINESS ADDRESS: STREET 1: HEMMELRATHER WEG 201 CITY: LEVERKUSEN STATE: 2M ZIP: D-51377 BUSINESS PHONE: 011 49 214 876 00 MAIL ADDRESS: STREET 1: HEMMELRATHER WEG 201 CITY: LEVERKUSEN STATE: 2M ZIP: D-51377 6-K 1 form6-k.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO

RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of February 2021

 

Commission File Number: 001-38396

 

BIOFRONTERA AG

(Registrant’s name / Translation of registrant’s name into English)

 

Hemmelrather Weg 201, D-51377 Leverkusen Germany

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F [X] Form:40-F [  ]

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): N/A

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): N/A

 

 

 

 

 

 

EXHIBITS

 

Exhibit Number   Description
99.1  

Release according to article 40 para. 1 WpHG

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  BIOFRONTERA AG
     
  By: /s/ Hermann Lübbert
  Name: Hermann Lübbert
  Title: Chief Executive Officer
     
  By: /s/ Thomas Schaffer
  Name: Thomas Schaffer
  Title: Chief Financial Officer

 

Date: February 25, 2021

 

 
 EX-99.1 2 ex99-1.htm

 

Exhibit 99.1

 

Release according to article 40 para. 1 WpHG

 

Leverkusen (pta/25.02.2021/17:30) - Release of Voting Rights Announcement

 

Voting Rights Announcement

 

1. Details of issuer:

 

Name: Biofrontera AG
Legal Entity Identifier (LEI): 391200D6GFSVFGFQTL13
Street: Hemmelrather Weg 201
Postal code: 51377
City: Leverkusen, Germany

 

2. Reason for notification: 

 

Change of breakdown of voting rights

 

3. Details of person subject to the notification obligation

 

Legal entity: Maruho Co., Ltd.
City of registered office, country: Osaka, Japan

 

4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3

 

Maruho Deutschland GmbH

 

5. Date on which threshold was crossed or reached

 

24.02.2021

 

6. Total positions

 

   % of voting rights attached to
shares (total of 7.a.)		   % of voting rights through
instruments (total of 7.b.1 + 7.b.2)		   Total of both in % (7.a. + 7.b.)   Total number of voting rights
pursuant to Sec. 41 WpHG		 
New   18.75    4.88    23.63    56,717,385 
Previous notification (if applicable)   22.27    5.79    28.06      

 

 
 

 

7. Details on total positions

 

a. Voting rights attached to shares (Sec.s 33, 34 WpHG)

 

ISIN  Absolute direct
(Sec. 33 WpHG)		   Absolute indirect
(Sec. 34 WpHG)		   In % direct
(Sec. 33 WpHG)		   In % indirect
(Sec. 34 WpHG)		 
DE0006046113   0    10,634,542    0.00    18.75 
Total:        10,634,542         18.75 

 

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG

 

Type of instrument  Maturity / Expiration   Exercise or conversion
period		   Voting Rights Absolute   Voting Rights in % 
Right of return from securities loan                   2,765,423    4.88 
         Total:    2,765,423    4.88 

 

b.2 Instruments according to Sec. 38 (1) no. 2 WpHG

 

Type of instrument  Maturity / Expiration   Exercise or conversion
period		   Cash or physical
transaction		   Voting Rights Absolute   Voting Rights in % 
                             0    0.00 
              Total:    0    0 

 

8. Information in relation to the person subject to the notification obligation

 

Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity

 

Name  % of voting rights (if at least
3% or more)		   % of voting rights through
instruments (if at least 5% or
more)		   Total of both (if at least 5% or
more)		 
Maruho Co., Ltd.               
Maruho Deutschland GmbH   18.75         23.63 

 

9. In case of proxy voting according to Sec. 34 para. 3 WpHG

 

(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

 

Date of general meeting: N/A

 

 
 

 

10. Other useful information

 

Date

25.02.2021

 

 

 

(end)

 

emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com

 

ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Dusseldorf, Frankfurt; free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate other stock exchanges: Nasdaq

 

 

 GRAPHIC 3 ex99-1_01.jpg begin 644 ex99-1_01.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH I75XMJ\,[G$#MY;G^Z3T)_'C\ M:NUCM'%?76JZ1/RCHL@'@ [9].IJ]:B:9%EGC\E/X(.ZC_:] M_;M[T[6%^(H+*R;ATT^ J[CTW,9:6=I%;-(O*F3<2<'\Q^%;/B?PAH_BZR%MJEON9/]5,AVR1G MV/\ 3I4_AWPWIOA?3%L-,A*1YW.['+R-ZL>YJ&Z\3P07;P16\DXC.'=2 ?; MUJTG*7[OH0VHQ]_JG# ?I71:=X1\/>"K*;5 MKIY+B6!#))=W;;V&/0= ?UKK;:XCN[:.>(Y1QD5YC\<]1GMO#6GV<9*QW5S^ M\([A1D#\SG\*J,ISER-B:C&/,CH?"AN?$\__ D^I(5A)*Z=;'I$G3>?5CZU MV54-$CAAT'3X[?'DK;1A,>FT5?K*3NS2*L@HHHJ1GE.A>,_B+XBT>/5=.T'2 M)K5RP7,Q5CM.#P6]JZ[PKXKF\5>&[J\BLOLVI6SR02VSMD+,HZ9].E>;?#S7 MO&=CX&MK?1/"T5]:JTGEW+7*KDECGY>O!KI/A[=P)X5U^RD2X@UV-YI]1BF7 M:PE<$Y7'\/'%=-2"5]%O_5S"$GIJ=WH,NJSZ+;2:W;Q6^HL#YT4)RJG)QCD] ML=ZT0020",CK7DT.NZC8_!/0Q9W#C4=2D2SBG8DLI=V!;/K@&CQ#X,3P%HJ^ M)]#U"_-_8LCW7G3EUND+ ,&'XU'L]=7U*Y]-CJO&VN:O:7FD:'H+PQ:EJDK@ M3S+N6)$&6;'WH=OWT4>P%>W'K7G7C+0++7_B+X5E>Y MO8TU."4OY4VTH%C!&WTSGGUJ7Q1I%_8>)?!V@:'JUS:YCN4^T3.9&"X!)/JV M"<9Z<4^5.*0N9IMGJM(""2 0<=:\NUW2KOP-X<:QTS6K^YO]=OH;1;BZDW-$ M6SN9?3BJ_B'PC'\/-+B\3Z%?7WVFSEC-XLTY=;F,L VX>O-2J:?7?8IS:Z'K M5("#T(->9^,K>[USX@^&]/L]5N;"&[LIVDD@;#%, D#T)'&>U0V6@IX#^)>B MVFEWEY)8ZO#,D\-Q+O\ G1=P;Z__ %Z%35M]0YW?8[73_$9OO&&KZ#]FV#3X MHI/.WYW[QG&,<8K>S@9->.6?@73]5^*'B>TFOM3C2)(9E:&Y*L3("2"<<@=A MVJYXKO\ 2[KQ=!X6UG6VT[0]/LTDE!GV/=2'A5+=P!R:;IINR["4VE=GJX(( MR#D45Y3X/OM)TCX@IHOAO6#?Z-?6CRF$SF46\J'L3T!%4O#OAC4_&$FOI=>( MK^TTV'5KA4@M7P[/GJ6/\(&,#ZTO96W>@_:7V1[$2!U('UI:\P\7Z!X,M;V& M;Q1XBO$=;>.**W^TD'"C&[:H)R>I-2?"?58[B?7M+LM0GO\ 2K.:-K*:XSO" M.#E>>< BCV?N\R#G]ZS/2ZYB7PU=)>3-:SQ"&9BQWYRN>OUKIZP/%7B:+PW8 M(RPM=7TYV6MJGWI&_P !2ISE%VCU'.,9*\NAKV5HEC9Q6R$D(,9/<]S7.?$+ MPI_PEWA:6SBP+R%A-;$]-X[?B"17('PK\1_$K?:]2\1?V2C\K;0,PV#TPO\ M4DU>M-*^(GA5A,FI1^(+1?OV\K'S,?[)/.?Q/TJ^6SYE)7)O=6Y="3X5>*&N M=-_X1O4PT.J:?F-4DX9D';ZKT^F*](K@;G1]*\+?%J6LMMIUW: M"WM?-7:TH1#E\>G'ZUZ,-,L ';ZSA::;2YH[[RU&2RI(V['X'/X5?\8^.-(\6^%ET+P] M<&\U+5F2)8%0YB&X%B_'& *]3CCCBC$<:*B#HJC 'X56M]+T^TG>>VL;:&9_ MO21Q*K-]2!1[17NUYBY':R9Q&N6XM/B+X#M@HP:J6VEZ?9S/-:V-M!*_WWBB52WU(%$9I)76P2@W>W4XO4XA! M\6O"<*\B/3[A1^"XJ3Q5_P E/\%?6Z_]%BNX,4;2K*8T,BC"N1R![&AHHWD2 M1HT9T^ZQ&2OT-'/MZ!R'FDNOZ=X1^+.NSZW.;2WU"S@:WF9"5;8,$<#K4&NW M.EZ'\0H_$6L6<=QH.L6,:+8L,@Y&00<97'^17IMS8VE[M^UVL$^PY7S8 MPV#[9J26WAF@,$L,22H]G-<0EP8=O M 3@X[5I_#G4H-7\:>+[^V@EA@F:V,:2IL;;L(!QVSU_&O0+K3;"]ECDN[*WG MDC^XTL2L5^A(XJ=(8HW9TC16?&Y@H!./6FZB:VU$H-,<2%!). .2:QM.TQ9] M4DUR[3=#3JS3L78****0S.O-(BGNUOK< MBWOT&!,H^^/[KC^(?R[5;4"Y@*7$*Y/#QL-P_P#KBIJ*=Q6(XX5A0)&651T& MH2:C!=6(@)2%XCYK$8W$<\#GI M6=+X9>-[81Q174:VZP2"65DQ@D[OEZYR>*X*DJ\9R<$_GMTV_&YZ%..'E"*F MU\M^N_X6-AM9M%OQ:?O"=XC,@3Y Y&0N?7%-LM"=SEF[ MC''2A5:_.HM=>W3^NHG1P_LW*+Z+KU_KH:4^KQV=W=B9W=8VB18XXLD%\XYS MSFK5KJ,%W9-=KN2-"P<2#!0KU!%9UWI%Q/J$\ZM'LDGMY!D\X3K5BWTR1=-O M[65E!N9)F!7G ?.*TC*MSM-::_K8B<:'(FGKI^E]"K#XCCDNKEWCECM(H$D4 M/&0[EF(&!WSQBK+>(+584?R;DR/*8O)$7SAP,X(^E9;:#J-W!,+D6Z/Y$,<8 M1R0QC;// P#5NUT:6.2RE%O#;F.X:654E9\@H5')ZGI6,)XG:WX>?Z&TX87> M_P!S\G^?=@!P M=WI5=M(N#>F;='M-^+GKSM";?SS69<^&K^2R2#$$O[J1 'D91&S.6## Y.#B MG*IBE>ROVT%&EA96N[=]?^ :L6NJ-1U*.='2VM45Q)LXQC)R??M22Z\)(HC; M(\GG_EMW^0*.&^+3IU\O\ /?MIW+\6NV4MR\(, MB@!RLC)A'V?>VGOBHX_$=E(K,8[B,*$;+QXRKG"M]*HQZ#>/LM9FB6U@$PB= M22S^8"!D8XQDU3MHY;A-42[$02"Q6W:2(EEW)N/4@<]#BI=?$*UU;?IY7[]. M_4I4,.[M.]K=?.W;KVZ'3Q7\4[S+$LC>5(8V(7C<,9Q^=%5]!MWM]&MQ+_KI :!YLA]6;D_P Z*[J;E*"D^IPU%&,W&.R/_]D! end